Associated Papers
Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death.
Lu Y et al.
Redox Biology, 2025
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S5
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers.
Hoskins EL et al.
Npj Precision Oncology, 2025
40610725 (PubMed )
Supplement: 41698_2025_889_MOESM5_ESM.xlsx › Sheet1
Fibroblast growth factor receptor 3 mutation promotes HSPB6-mediated cuproptosis in hypochondroplasia by impairing chondrocyte autophagy.
Chen J et al.
Journal of Orthopaedic Translation, 2025
Identification of a novel mutation of FGFR3 gene in a large Chinese pedigree with hypochondroplasia by next-generation sequencing: A case report and brief literature review.
Yao G et al.
Medicine, 2019
Identification of a novel mutation in the FGFR3 gene in a Chinese family with Hypochondroplasia.
Chen J et al.
Gene, 2018
Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations.
Gallo LH et al.
Cytokine & Growth Factor Reviews, 2015
FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.
Bodoor K et al.
Cancer Epidemiology, 2010
The strong dimerization of the transmembrane domain of the fibroblast growth factor receptor (FGFR) is modulated by C-terminal juxtamembrane residues.
Peng WC et al.
Protein Science : a Publication of the Protein Society, 2009
Forster resonance energy transfer measurements of transmembrane helix dimerization energetics.
Merzlyakov M et al.
Methods in Enzymology, 2008
Studies of receptor tyrosine kinase transmembrane domain interactions: the EmEx-FRET method.
Merzlyakov M et al.
The Journal of Membrane Biology, 2007
Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.
Li E et al.
Biochemistry, 2006
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b.
Bernard-Pierrot I et al.
Carcinogenesis, 2006
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.
Ronchetti D et al.
Oncogene, 2001
Select a paper to view details